Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IKBKAP | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | SART3 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | CHERP | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | HNRNPD | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | RPA1 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
mRNA | CAD | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | SLC25A15 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | TMEM106A | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
mRNA | RAD51 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | RNF14 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |